recall
saveProRx LLC recall (Cls II)
November 5, 2025updated 5mo ago
community read0 votes
Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09 — Reason: Lack of Assurance of Sterility — Status: Ongoing
view source ↗Data sources
last refreshed 38m ago
Found something off?
same company · ±60 days · 6
🐶 often sniffed alongside
top 7- companyNovo Nordisk Inc2 co-mentions · 2 sources
- tagHepatology2 co-mentions · 1 sources
- tagObesity2 co-mentions · 1 sources
- tagEndocrinology & Metabolism1 co-mentions · 1 sources
- drugObesity1 co-mentions · 1 sources
- drugzalfermin1 co-mentions · 1 sources
- drugcagrilintide hydrochloride1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that